Considerations for CPX-351 in Acute Myeloid Leukemia

1 Views
administrator
administrator
07/04/23

Expert panelists Eunice Wang, MD; Harry Erba, MD, PhD; Alexander E. Perl, MD; and Jorge E. Cortes, MD, identify important considerations when treating acute myeloid leukemia with CPX-351, such as its toxicity profile and patient stratification.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next